Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lyra Influenza A+B Assay

K-Number: K230236 · 2023-03-03

Decision Date2023-03-03
Product CodeOZE
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Lyra Influenza A+B Assay is a medical device manufactured by Quidel Corporation. It received FDA 510(k) clearance on 2023-03-03 under approval number K230236. The device is classified under product code OZE. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lyra Influenza A+B Assay?

Lyra Influenza A+B Assay is a medical device that received FDA 510(k) clearance on 2023-03-03. It is manufactured by Quidel Corporation. The 510(k) number is K230236.

When was Lyra Influenza A+B Assay approved by the FDA?

Lyra Influenza A+B Assay received FDA 510(k) clearance on 2023-03-03, under approval number K230236.

What company makes Lyra Influenza A+B Assay?

Lyra Influenza A+B Assay is manufactured by Quidel Corporation.

What is the FDA product code for Lyra Influenza A+B Assay?

The FDA product code for Lyra Influenza A+B Assay is OZE.

Other Devices by Quidel Corporation

View all 23 devices →

Related Devices (Code: OZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.